Ryan McLaughlin, Ph.D

From Seed to Synapse: Modeling the Long-Term
Impacts of Developmental Cannabis Exposure

March 14, 2024, 1 PM MST

Dr. Ryan McLaughlin is an Associate Professor in the Department of Integrative Physiology and Neuroscience at Washington State University (WSU). The overarching goal of Dr. McLaughlin’s research program is to determine how endogenous and exogenous cannabinoids affect the brain and behavior. His research has shown that the endocannabinoid system is a vital component of the neuroendocrine and behavioral response to stress, and that pharmacological targeting of this system can be a promising therapeutic strategy for treating stress-related dysfunction. Dr. McLaughlin is a recipient of the Healthy Minds Canada Prize in Children’s Mental Health and his research team is currently funded by federal grants from the National Institute on Drug Abuse (NIDA) and the National Institute of Mental Health (NIMH). He has over 45 peer-reviewed publications in nationally recognized scientific journals, including Biological Psychiatry, Proceedings of the National Academy of Sciences, Journal of Neuroscience, Neuropsychopharmacology, and Pain, and has authored several book chapters detailing the role of the endocannabinoid system in the regulation of stress and emotional behavior. His research has been covered in various news media outlets, including Forbes, Scientific American, The Scientist, The Seattle Times, and The Washington Post.

Previous Webinars

Igor Grant, M.D. and Thomas Marcotte, Ph.D.

Thursday, February 12th at 1:00 PM MST

The UC San Diego Center for Medicinal Cannabis Research: Some Findings

Igor Grant, MD is Distinguished Professor, and Director of the Center for Medicinal Cannabis Research (CMCR) at the University of California San Diego (UCSD). Established in 2000, the CMCR has been at the forefront of advancing science and policy […]

Read More »

Almut Winterstein, PhD.

Jan 8, 2026 01:00 PM Mountain Time

Clinical research priorities gleaned real-world use patterns: the MEdical Marijuana Outcomes Research repositorY (MEMORY)

Almut Winterstein is Distinguished Professor and the Dr. Robert and Barbara Crisafi Chair for Medication Safety in the Department of Pharmaceutical Outcomes and Policy and in the Department of Epidemiology, and the founding Director of the […]

Read More »

Carolyn Baglole, PhD,

December, 11, 2025 1:00 PM MST

Multi-omics dissection of the molecular and pharmacological effects of inhaled cannabis

Professor Carolyn Baglole earned her Bachelor of Science and Master of Science degrees from the University of Prince Edward Island, followed by a PhD in Physiology and Pharmacology from the University of Calgary. Dr. Baglole then completed postdoctoral training at […]

Read More »

Margaret Haney, PhD

Nov 13, 2025 01:00 PM MST

Cannabis Misuse and Therapeutic Potential: Placebo-controlled Laboratory Studies

Dr. Margaret (Meg) Haney is a Professor of Neurobiology (in Psychiatry) at the Columbia University Irving Medical Center. As the Director of the Cannabis Research Laboratory and of the Substance Use Research Center in the Division of Substance Use Disorders, Dr. Haney is […]

Read More »

Inga Zasada, Ph.D.

Wednesday, February 18 at 11:00 AM MST

Dr. Inga Zasada brings over 25 years of expertise in nematology, specializing in the biology and management of plant-parasitic nematodes affecting high-value crops such as hemp. With deep knowledge spanning both chemical and nonchemical control strategies, she provides comprehensive solutions for complex nematode challenges. As owner of NemaSolutions LLC, […]

Read More »

Dan Ovadya, CEO

New Methods for Induction of Male Flowers and Scalable Feminized Seed Production in Cannabis Sativa

Dan Ovadya is the Co-founder and CEO of FloraGen LLC, an AgTech company based in Davis, California. Dan has
over 30 years of experience in crop optimization, precision horticulture and seed production systems in controlled
environments. His career in Ag-Biotech centered on developing […]

Read More »